Actively building life science companies

5AM Ventures is a leading venture capital firm focused on building next-generation life science companies capable of delivering outstanding returns to our investors.

Scroll to experience 5AM Ventures

Supporting companies that are working to solve important healthcare needs via cutting-edge breakthroughs in medicine and science.

Read Me

Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein Degrader ARV-471
Read Me

TMRW Life Sciences Raises $105 Million to Accelerate Global Rollout of World’s First Automated Platform for IVF Egg & Embryo Management
Read Me

Ninilchik Village Tribe Will Provide Access to Prescription Digital Therapeutics to Help Alaskan Community Treat Rural Patients with Substance and Opioid Use Disorder
Read Me

Escient Pharmaceuticals Announces Positive Results From Phase 1 Study Of EP547, An MrgprX4-Targeted Oral Therapy For Cholestatic And Uremic Pruritus
Read Me

Pear Therapeutics Reports Nine-Month Real-World Healthcare Utilization Data for reSET-O®

Pushing the healthcare industry forward

$ 0 B

UNDER MANAGEMENT

We’re a life science venture capital firm founded in 2002 and currently investing $350M from 5AM Ventures VI and $147M from 5AM Opportunities I.
0

PORTFOLIO COMPANIES

Our focus is biopharmaceuticals, drug delivery technologies and life science instruments.
0

ONGOING CLINICAL TRIALS

Our portfolio companies currently have over 50,000 patients enrolled across 4,700 test sites in ongoing clinical trials.

San Francisco, CA

Boston, MA

© 2021 5AM Venture Management LLC